Sigma Healthcare (SIG) - FY25 result analysis

Injecting leverage into sales

Published: 10 September 2025

Sigma reported FY25 network sales growth for Chemist Warehouse of 14% and EBIT at $903 million, up 47%. The company reported a continuation of double-digit like-for-like sales growth with a lift in profit margins for the underlying Chemist Warehouse business. We forecast EBIT growth of 22% in FY26e ahead of revenue growth of 15%. Margins will be helped by penetration of Wagner private label, operating leverage from strong comp sales and the increasing synergies over the next four years.

Not already a member?
Join now to get all the latest reports in full and stay informed.

Get started